Quantedge Capital Pte LTD Corcept Therapeutics Inc Transaction History

Quantedge Capital Pte LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$22.21 - $34.48 $3.44 Million - $5.34 Million	-154,800 Reduced 85.69%	25,842 $839,000
Q1 2024 May 14, 2024	SELL	$21.1 - $27.46 $1.43 Million - $1.86 Million	-67,700 Reduced 27.26%	180,642 $4.55 Million
Q4 2023 Feb 13, 2024	BUY	$24.82 - $32.88 $6.16 Million - $8.17 Million	248,342 New	248,342 $8.07 Million
Q1 2023 May 12, 2023	SELL	$19.2 - $24.47 $3.78 Million - $4.82 Million	-196,800 Reduced 78.31%	54,512 $1.18 Million
Q4 2022 Feb 14, 2023	BUY	$19.95 - $29.96 $151,620 - $227,696	7,600 Added 3.12%	251,312 $5.1 Million
Q3 2022 Nov 10, 2022	SELL	$24.7 - $29.12 $1.99 Million - $2.35 Million	-80,700 Reduced 24.88%	243,712 $6.25 Million
Q2 2022 Aug 12, 2022	BUY	$17.33 - $25.3 $3.66 Million - $5.35 Million	211,400 Added 187.06%	324,412 $7.72 Million
Q1 2022 May 13, 2022	BUY	$16.53 - $25.21 $1.61 Million - $2.46 Million	97,700 Added 638.06%	113,012 $2.55 Million
Q4 2021 Feb 11, 2022	BUY	$17.1 - $23.34 $261,835 - $357,382	15,312 New	15,312 $303,000

355

86.2M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Quantedge Capital Pte LTD, based on Form 13F filings with the SEC.

Stay updated on Quantedge Capital Pte LTD with notifications on news.